Taaneh Overview

  • Founded
  • 2014
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $1.6M
Latest Deal Amount
  • Investors
  • 1

Taaneh General Information


Developer of anti-counterfeiting systems using diamond particles. The company engages in commercializing the use of diamond particles for the authentication, identification and construction of anti-counterfeiting systems in the pharmaceutical and other industries.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Commercial Products
Other Industries
Other Healthcare
Primary Office
  • 31 West 31st Street
  • 10th Floor
  • New York, NY 10001
  • United States
+1 (609) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Taaneh Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 06-Jan-2015 $1.6M 00.00 Completed Startup
To view Taaneh’s complete valuation and funding history, request access »

Taaneh Executive Team (1)

Name Title Board Seat Contact Info
Andrew Janoff Ph.D Chief Executive Officer & Chairman
To view Taaneh’s complete executive team members history, request access »

Taaneh Board Members (1)

Name Representing Role Since
Andrew Janoff Ph.D Taaneh Chief Executive Officer & Chairman 000 0000
To view Taaneh’s complete board members history, request access »

Taaneh Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Scientia Ventures Venture Capital Minority 000 0000 000000 0
To view Taaneh’s complete investors history, request access »